Hans Bostrom has over 20 years experience as an equities analyst at leading firms including Goldman Sachs, BNP Paribas, and Credit Suisse. He has covered medtech and healthcare services companies of all sizes across the UK, Continental Europe, Middle East and Africa, and has been involved in numerous IPO and M&A transactions.

He holds an MSc in Financial Economics (Stockholm School of Economics), and was number two ranked for Medtech and Healthcare Services in the Institutional Investor annual survey from 2005-10.